RxSight, Inc.
RXSTNasdaqCIK 1111485HealthcareFiscal year ends Dec 31
Reports and events: 85 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-08-0716:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039068 |
| 2023-07-0506:04 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0000950170-23-031482 |
| 2023-06-0516:52 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-160781 |
| 2023-06-0218:30 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-025787 |
| 2023-05-0916:18 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-019703 |
| 2023-05-0916:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-019669 |
| 2023-04-2016:28 ET | DEF 14A | Proxy statementPeriod 2023-06-01 | 0000950170-23-013694 |
| 2023-03-0616:09 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-006237 |
| 2023-03-0616:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-006234 |
| 2023-02-0809:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-027742 |
| 2023-01-0906:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-000394 |
| 2022-12-1213:02 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-22-026362 |
| 2022-11-0716:16 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-022617 |
| 2022-11-0716:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-022592 |
| 2022-08-0817:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-22-215003 |
| 2022-08-0816:11 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-015528 |
| 2022-08-0816:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-015514 |
| 2022-07-1117:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-012611 |
| 2022-06-0214:41 ET | 8-K | 5.07 Shareholder vote results | 0000950170-22-011072 |
| 2022-05-0516:32 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-007878 |
| 2022-05-0516:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-007845 |
| 2022-04-2116:02 ET | DEF 14A | Proxy statementPeriod 2022-06-02 | 0000950170-22-005917 |
| 2022-04-0616:30 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0000950170-22-005408 |
| 2022-03-0816:31 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-003135 |
| 2022-03-0816:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-003130 |
| 2022-01-1006:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-000156 |
| 2022-01-0416:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-22-000038 |
| 2021-11-1017:02 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-004155 |
| 2021-11-1016:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-21-004078 |
| 2021-09-0917:01 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000950170-21-001744 |
| 2021-09-0916:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-21-001738 |
| 2021-08-1317:15 ET | SC 13D | Ownership report, active investor | 0001193125-21-246230 |
| 2021-07-2821:48 ET | S-1/A | Registration statement, amended | 0001193125-21-226143 |
| 2021-07-2608:02 ET | S-1/A | Registration statement, amended | 0001193125-21-223690 |
| 2021-07-0915:58 ET | S-1 | Registration statement | 0001193125-21-211793 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 03:37 ET. Listed shows no prices and gives no investment advice.